Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Hits New 1-Year Low at $51.60

Shares of Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $51.60 and last traded at $51.60, with a volume of 0 shares trading hands. The stock had previously closed at $51.60.

Recordati Industria Chimica e Farmaceutica Price Performance

The company’s 50 day moving average price is $51.60 and its 200-day moving average price is $51.05. The stock has a market cap of $10.65 billion, a P/E ratio of 18.63 and a beta of 0.29. The company has a quick ratio of 0.95, a current ratio of 1.36 and a debt-to-equity ratio of 0.73.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last released its quarterly earnings results on Thursday, May 9th. The company reported $0.85 earnings per share (EPS) for the quarter. The firm had revenue of $659.94 million during the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 18.18% and a return on equity of 30.58%. As a group, sell-side analysts expect that Recordati Industria Chimica e Farmaceutica S.p.A. will post 2.81 earnings per share for the current year.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.